Haematopoietic stem cell transplants should be a second-line therapy for highly active MS - Commentary

Ellen M. Mowry

Research output: Contribution to journal › Short survey › peer-review

1 Scopus citations

Fingerprint

Dive into the research topics of 'Haematopoietic stem cell transplants should be a second-line therapy for highly active MS - Commentary'. Together they form a unique fingerprint.